- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
BioCentury | Jul 11, 2017
Emerging Company Profile
Complementary ALS play
Why Alsonex is targeting the complement system at C5a to treat ALS
BioCentury | Feb 3, 2014
Emerging Company Profile
ImStar: Neuronal pacifier
ImStar believes blocking a kinase interaction may reduce inflammation in ALS
BioCentury | Mar 11, 2013
Emerging Company Profile
FPRT Bio: Neutralizing neuroinflammation
FPRT Bio's soluble TNF mimic blocks inflammation that drives ALS and PD
BioCentury | Oct 29, 2012
Emerging Company Profile
Regenesance: Stopping the MAC attack
Regenesance developing anti-C6 mAbs for myasthenia gravis
Items per page:
1 - 6 of 6